MLchartDataset catalogue

FOLFIRI-Avastin regimen

Term · Oncology and biomedicine · MLC-T-ONC-003287

A chemotherapy combination used as an initial treatment of colorectal cancer that has spread. It includes the drugs leucovorin (folinic acid), fluorouracil, irinotecan hydrochloride, and bevacizumab. Also called FOLFIRI-bevacizumab and FOLFIRI-bevacizumab regimen.

Table 1. Record
IdentifierMLC-T-ONC-003287
FieldOncology and biomedicine
SynonymsFOLFIRI-bevacizumab; FOLFIRI-bevacizumab regimen
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-003287",
  "term": "FOLFIRI-Avastin regimen",
  "field": "Oncology and biomedicine",
  "definition": "A chemotherapy combination used as an initial treatment of colorectal cancer that has spread. It includes the drugs leucovorin (folinic acid), fluorouracil, irinotecan hydrochloride, and bevacizumab. Also called FOLFIRI-bevacizumab and FOLFIRI-bevacizumab regimen.",
  "synonyms": [
    "FOLFIRI-bevacizumab",
    "FOLFIRI-bevacizumab regimen"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/folfiri-avastin-regimen/"
}

Record 7,524 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.